✦ LIBER ✦

Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection

✍ Scribed by K. Sahora MD, M. Schindl MD, I. Kuehrer MD, G. Werba MD, F. Fitzal MD, P. Goetzinger MD, M. Gnant MD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resectability After Concurrent Gemcitabi

✍ Skamene, S.; Niazi, T.; Kopek, N.; Vanounou, T.; Vuong, T. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

W1684 Gemcitabine-Based Adjuvant Chemoth

✍ Wada, Keita; Amano, Hodaka; Miura, Fumihiko; Toyota, Naoyuki; Kato, Kenichiro; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Induction gemcitabine-based chemotherapy

✍ Michael D. Chuong, Gregory M. Springett, Jill Weber… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 306 KB

Pathologic Response With Neoadjuvant Che

✍ Rajagopalan, M.S.; Heron, D.E.; Zeh, H.J.; Moser, A.J.; Krasinskas, A.M.; Quinn, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Prospective efficacy and safety study of

✍ Lee, Jae-Lyun; Kim, Song Cheol; Kim, Ji-Hoon; Lee, Sang Soo; Kim, Tae-Won; Park, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 455 KB

397. Combination of Preoperative Gemcita

✍ Yoshitomi, H.; Shimizu, H.; Yoshidome, H.; Ohtsuka, M.; Kato, A.; Furukawa, K.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB